1 – 15 of 15
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Real-world analysis of MET exon 14 mutations in non-small cell lung cancer : a retrospective study from two Swedish hospitals
(
- Contribution to journal › Article
- 2017
-
Mark
Reaching the limits of prognostication in non-small cell lung cancer : an optimized biomarker panel fails to outperform clinical parameters
(
- Contribution to journal › Article
- 2016
-
Mark
Profiling cancer testis antigens in non-small-cell lung cancer
(
- Contribution to journal › Article
- 2014
-
Mark
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
(
- Contribution to journal › Article
- 2013
-
Mark
The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma
(
- Contribution to journal › Article
-
Mark
Swedish Lung Cancer Radiation Study Group: Predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
CD99 is a novel prognostic stromal marker in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
The Value of Induction Chemotherapy for Survival in Patients with Non-small Cell Lung Cancer Treated with Radiotherapy
(
- Contribution to journal › Article
- 2003
-
Mark
Ligand-induced recruitment of Na+/H+-exchanger regulatory factor to the PDGF (platelet-derived growth factor) receptor regulates actin cytoskeleton reorganization by PDGF.
(
- Contribution to journal › Article
- 2002
-
Mark
SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF-beta receptor
(
- Contribution to journal › Article
- 1999
-
Mark
Functional co-operation between the subunits in heterodimeric platelet-derived growth factor receptor complexes
(
- Contribution to journal › Article
-
Mark
Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding
(
- Contribution to journal › Article
- 1998
-
Mark
Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins
(
- Contribution to journal › Article